APA (7th ed.) Citation

BJ, M., TW, C., & JS, S. (2025). Primary Resistance to RET Inhibition in a RET Fusion-Positive Pancreatic Neuroendocrine Carcinoma. The oncologist, 30(1), . https://doi.org/10.1093/oncolo/oyae034

Chicago Style (17th ed.) Citation

BJ, McKinley, Coston TW, and Starr JS. "Primary Resistance to RET Inhibition in a RET Fusion-Positive Pancreatic Neuroendocrine Carcinoma." The Oncologist 30, no. 1 (2025). https://doi.org/10.1093/oncolo/oyae034.

MLA (9th ed.) Citation

BJ, McKinley, et al. "Primary Resistance to RET Inhibition in a RET Fusion-Positive Pancreatic Neuroendocrine Carcinoma." The Oncologist, vol. 30, no. 1, 2025, https://doi.org/10.1093/oncolo/oyae034.